GluBio Therapeutics
PrivateLast Round
Strategic
Feb 11, 2026
Total Funding Raised
$122M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GluBio Therapeutics is a biotechnology company that discovers and develops innovative molecular glue-targeted protein degradation drugs to address unmet medical needs in oncology, autoimmune diseases, and genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GluBio Therapeutics Comparables
Compare GluBio Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Plexium | 88% | |
| SEED Therapeutics | 84% | |
| Neomorph | 84% | |
GluBio Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Feb 11, 2026 | ||||
| Series A Extension | Aug 1, 2022 | ||||
| Series A | Feb 28, 2022 | ||||
| Seed | Feb 1, 2021 |
Key People
Founding team and executive leadership
GluBio Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hillhouse Investment | Series A |
| Kaitai Capital | Series A, Series A Extension, Seed |
| Legend Capital | Series A |
| E Fund Management | Series A |
| 险峰K2VC | Series A, Seed |
| Lilly Asia Ventures | Series A, Series A Extension |
| Qiming Venture Partners | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 56% MoM.
- Jan 19, 2026
Monthly visitors grew 1574% MoM, from 23 to 385.
GluBio Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about GluBio Therapeutics's valuation, stock price, and market status.